Lv2
120 积分 2025-10-09 加入
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
3个月前
已完结
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
3个月前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
5个月前
已完结
不确定性估计在药物设计中的方法研究与应用
5个月前
已采纳
维持性血液透析患者肺动脉高压的研究进展
5个月前
已采纳
重组人促甲状腺素介导分化型甲状腺癌的131I治疗
5个月前
已采纳
皖公网安备34019202002308
